|
The files are password
protected for members. Please contact us if you forgot your
username and password or for new members, to obtain one. Click
on the highlighted/colored portion to open. Some of these are large
files and may take a some time to download and open. They should
open in Adobe Acrobat Reader. You will need Adobe Acrobat
Reader (free download from Adobe).
If the file does not appear, or adobe opens but you get a blank
screen, (primarily for Acrobat 5.0 Reader users in Internet Explorer
6.0 and NT or XP systems), you will need to open Acrobat Reader, and
select preferences in the Edit menu. Click options and uncheck
the open in browser box if checked. This should fix the
problem and Adobe files will open in a new window.
Clicking the back button when finished viewing the file will return
you to the summaries page if it opened in the browser. If
opened in a new window, simply close the window to return to the
SFAI summaries page.
March 30, 2005
Estrogen receptor analysis of breast
cancer: Is quantiative better?: Dr. Allen Gown
Application of Silver Based Chromogenic In-situ Hybridization
(SISH) and IHC to Surgical Pathology Diagnosis (2 parts): Drs. Thomas Grogan and Richard N. Eisen
FISH Analysis of Tumors With Quantitative
Methods: Dr. Allen Gown
October 4, 2003
Neurodegenerative diseaeses and IHC:
Dr. Mark Edgar
CNS Tumors and IHC: Dr. Mark Edgar
Identification and Treatment of Prion
Diseases: Dr. Richard Kascsak
Alzheimer's Disease:
Therapeutic Strategies: Dr. Thomas Wisniewski
Comparative Veterinary Oncology and
Pathology: Dr. Philip
Bergman
Emerging Infectious Diseaes and
IHC: Dr.
Sherif Zaki
May 21, 2003
P16 IHC in Cervical Smears and
Surgical Material: Dr. William J. Klump
CDX2: A New Marker of Intestinal
Differentiation: Drs.
Richard W. Cartun and Richard N. Eisen
CK 7 Positive, CK20 Negative Colon
Carcinomas:
Dr. Neal Goldstein
Synthetic peptides
as novel quality control for quantitative IHC: Dr. Steven Bogen: coming
soon
October 26, 2002
Bioinformatics and Breast Cancer: Dr.
Federico Monzon
The ErbB Family: Therapeutic
Target and Diagnostic Dilemma: Albert J. Kovatich,
MS
Biomarkers in DCIS: Dr. Juan
Palazzo
Optimal Fixation Times for ER
Analysis:
Dr. Neal Goldstein
Phosphorylated Her-2/neu and EGFR as prognostic
factors in breast cancer: Dr. Michael
DiGiovanna
July 17, 2002
Pulmonary Neoplasia and Mesothelioma
Update: Dr. Douglas
Flieder
May 22, 2001
MUC proteins and neoplasia:
Dr. Volkan
Adsay
P504S: A novel marker of prostate cancer:
Dr. Zhong
Jiang
P63: Immunohistochemical applications:
Dr. Allen
Gown
Sept. 8, 2001
Dr. Mark Wick:
Prognostic and
Predictive Tests in Anatomic Pathology
Immunohistology in
Neoplastic Dermatopathology
Diagnostic
Immunohistology in Selected Urologic Neoplasms
Diagnostic
Immunohistology in Urologic Path
Dr. Rodney Miller:
Technical
Immunohistochemistry
Meeting: January 17,
2001
Case Presentation:
Dr. James Weisberger
Gynecologic Pathology
and IPOX update: Dr. Robert Soslow
WT1 antibody and
diagnostic pathology: Dr. Allen Gown
Meeting: November 4,
2000
Prognostic
Markers in Colorectal Cancer: Juan Palazzo, M.D.
Hereditary
Non-Polyposis Colorectal Carcinoma: Dr. Tina Bocker Edmonston
The Use of
Cytokeratins in GE Junction Pathology: Dr. Robert Odze, M.D.
Immunohistochemistry of Pancreaticobiliary
Adenocarcinomas: Neal Goldstein,
M.D.
Liver from Bone Marrow in Humans: Dr.
Neil Theise
1-Canals of
Hering and Stem Cells
2-Liver from
mouse bone marrow
3-Liver from human
bone marrow
Meeting: July 26,
2000
The Workup of Renal Biopsies: Dr. Vivette
D'Agati
Meeting: April 19, 2000
Case
Presentations: Metastases to the GI Tract : Dr. Federico
Monzon
A Holistic Approach
to Antigen Retrieval: David Tacha, HT/HTL (ASCP)
Chemokines in Hodgkin's Disease: Dr.
Julie Teruya-Feldstein
|